"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA)-related rulings from around the country. The following rulings were reported on HISA's “rulings” portal ...

The mean age of patients treated with dexamethasone was 36.27 ± 13.38 and in group treated with intravenous propofol was 35.65 ± 12.55 years. Independent T-test results showed no significant ...

and intravenous dexamethasone (0.15 mg/kg to a maximum of 16 mg, slowly), in group I and II, respectively. Pain explained by patients, based on VAS (Visual Analogue Scale) was recorded at the time ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with ...

DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

The EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending a change to the terms of the marketing ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD30-directed antibody-drug conjugate (ADC ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

The Horseracing Integrity and Welfare Unit also posted suspensions and fines for Dr. Benjamin Bealmear for possessing a ...